Androgen deprivation and SARS-CoV-2 in men with prostate cancer
- PMID: 32615154
- PMCID: PMC7323668
- DOI: 10.1016/j.annonc.2020.06.015
Androgen deprivation and SARS-CoV-2 in men with prostate cancer
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Comment on
-
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6. Ann Oncol. 2020. PMID: 32387456 Free PMC article.
References
-
- Mostaghel E.A., Page S.T., Lin D.W. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res. 2007;67:5033–5041. - PubMed
-
- Mikkonen L., Pihlajamaa P., Sahu B. Androgen receptor and androgen-dependent gene expression in lung. Mol Cell Endocrinol. 2010;317:14–24. - PubMed
-
- Wright P., Wilding S., Watson E. Key factors associated with social distress after prostate cancer: results from the United Kingdom life after prostate cancer diagnosis study. Cancer Epidemiol. 2019;60:201–207. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
